# AstraZeneca Pharma India Ltd (ASTRAZEN)
> Exchange: NSE | Sector: Pharma | ISIN: INE203A01020

## Price
Current Price: ₹8587.5
Day Change: -0.02%
52W High: ₹10691
52W Low: ₹7551.5
Market Cap: ₹21,362 Cr

## Valuation
P/E: 106.22
P/B: 26.73
EPS: ₹80.45
Book Value: ₹319.63
Dividend Yield: 0%

## Returns
1Y Return: -6.18%

## Profitability
ROE: 0%
ROCE: 156.44%
Debt/Equity: 0.04
Revenue Growth: 38.9%
Profit Growth: 5.7%
EBITDA Margin: 13.67%
Operating Margin: 6.7%

## About
AstraZeneca Pharma India Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: AstraZeneca Pharma India Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- Announcement: Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- BSE Filing: Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-25T05:24:22.761Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:22.761Z
Quant Updated: 2026-05-25T05:24:22.761Z
Sentiment Updated: 2026-05-25T05:24:22.761Z
Financials Status: current
Financials Updated: 2026-05-18T09:30:09.017Z
Financials Last Attempt: 2026-05-18T09:30:09.017Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹1713.29 Cr
Operating Profit: ₹214.81 Cr (OPM 12.54%)
Net Profit: ₹115.74 Cr
Tax: ₹40.62 Cr

## Annual P&L History
FY25: Rev ₹1713.29Cr | PAT ₹115.74Cr | OPM 12.54%
FY24: Rev ₹1295.53Cr | PAT ₹161.51Cr | OPM 13.23%
FY23: Rev ₹1002.97Cr | PAT ₹99.29Cr | OPM 14.84%

## Balance Sheet (FY25)
Total Assets: ₹1518.12 Cr
Total Liabilities: ₹747.77 Cr
Borrowings: ₹35.73 Cr
Cash: ₹536.14 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Bhavana  Agrawal, Whole-Time Director & CFO
- Praveen Rao Akkinepally, MD & Director
- Tanya  Sanish, Company Secretary & Compliance Officer
- Sandhya  Amanna, Director of Legal
- Smita  Saha, Vice President of Human Resources

---
Source: rupiya.io/stocks/astrazen
Disclaimer: For research and education only. Not investment advice.